Risk of death persists in heart patients with acute kidney injury

May 14, 2008

Acute kidney injury (AKI), a common complication of cardiac surgery during hospitalization, is linked to increased and prolonged risk of death in heart attack patients who have been discharged from the hospital, according to a study published in Archives of Internal Medicine by Yale School of Medicine researchers.

Led by Chirag Parikh, M.D., associate professor in the Department of Internal Medicine at Yale School of Medicine, the study examined the relationship between AKI and long-term mortality risk in 147,000 elderly patients enrolled in the Cooperative Cardiovascular Project.

"We found that among myocardial infarction patients, there was an association with increased and long-term risk of death for surgery patients who made it out of the hospital," said Parikh. "The risk of death did not appreciably dissipate over time, and was still considerable for those who survived the first three years of follow-up."

The research team graded the relationship between AKI and long-term risk of death. Those with mild, moderate and severe AKI had a 15, 23 and 33 percent increased risk of death respectively after accounting for other known risk factors. For all severities of AKI, there was a consistent link to increased long-term risk of death. AKI was also stronger than other long-term mortality predictors such as diabetes, heart failure, lung disease and chronic kidney disease.

Parikh said that clinicians commonly view AKI as a reversible syndrome and that patients with AKI may benefit from a long-term outpatient follow-up after discharge.

"Future efforts should be undertaken to understand the biology of this relationship between AKI and mortality, and efforts to prevent and treat AKI should be continued," said Parikh.
Other authors on the study include Steven G. Coca, Yongfei Wong, Frederick Masoudi and Harlan Krumholz, M.D.

Citation: Archives of Internal Medicine Vol. 168, 9 (May 12, 2008)

Yale University

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.